Abciximab in Wake-up Stroke

NCT00167765 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Higher hemorrhage rates of Abciximab in ABESST II trial

Conditions

Stroke

Interventions

DRUG: Abciximab

Sponsor

University of Zurich

Collaborators

[object Object]